(Q40765693)

23 September 2017

The incidence and pathogenesis of cardiopulmonary deterioration after abrupt withdrawal of inhaled nitric oxide (English)

1 reference

23 September 2017

0 references

J Christenson

1

1 reference

23 September 2017

A Lavoie

2

1 reference

23 September 2017

M O'Connor

3

1 reference

23 September 2017

S Bhorade

4

1 reference

23 September 2017

A Pohlman

5

1 reference

23 September 2017

J B Hall

6

1 reference

23 September 2017

language of work or name

English

0 references

publication date

1 May 2000

1 reference

American Journal of Respiratory and Critical Care Medicine

23 September 2017

1 reference

23 September 2017

161

1 reference

23 September 2017

1443-1449

1 reference

23 September 2017

5

1 reference

Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide

23 September 2017

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.5.9806138

Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.5.9806138

Inhaled nitric oxide in persistent pulmonary hypertension of the newborn

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.5.9806138

Hemodynamic and gas exchange responses to infusion of acetylcholine and inhalation of nitric oxide in patients with chronic obstructive lung disease and pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.5.9806138

Inhaled nitric oxide as a screening vasodilator agent in primary pulmonary hypertension. A dose-response study and comparison with prostacyclin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.5.9806138

Hemodynamic effects of inhaled nitric oxide in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.5.9806138

Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. The Inhaled Nitric Oxide Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.5.9806138

Physiologic determinants of the response to inhaled nitric oxide in patients with acute respiratory distress syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.5.9806138

Inhaled nitric oxide in neonatal and pediatric acute respiratory distress syndrome: dose response, prolonged inhalation, and weaning.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.5.9806138

Nitrogen dioxide production during mechanical ventilation with nitric oxide in adults. Effects of ventilator internal volume, air versus nitrogen dilution, minute ventilation, and inspired oxygen fraction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.5.9806138

Life-threatening effects of discontinuing inhaled nitric oxide in severe respiratory failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.5.9806138

Metabolic cataracts in newly diagnosed diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.5.9806138

An expanded definition of the adult respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.5.9806138

The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.5.9806138

Negative feedback regulation of endothelial cell function by nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.5.9806138

10.1164/AJRCCM.161.5.9806138

21 January 2018

Identifiers

DOI

1 reference

23 September 2017

1 reference